P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS.
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000972304.71265.f8 |
| _version_ | 1797281600861372416 |
|---|---|
| author | Nawid Albinger Tobias Bexte Ahmad Al-Ajami Philipp Wendel Leon Buchinger Alec Gessner Jamal Alzubi Vinzenz Särchen Meike Vogler Raj Bhayadia Jan-Henning Klusmann Nina Möker Toni Cathomen Michael A. Rieger Katharina Imkeller Evelyn Ullrich |
| author_facet | Nawid Albinger Tobias Bexte Ahmad Al-Ajami Philipp Wendel Leon Buchinger Alec Gessner Jamal Alzubi Vinzenz Särchen Meike Vogler Raj Bhayadia Jan-Henning Klusmann Nina Möker Toni Cathomen Michael A. Rieger Katharina Imkeller Evelyn Ullrich |
| author_sort | Nawid Albinger |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:59:47Z |
| format | Article |
| id | doaj.art-32437ed97ea740149ecb01b64eed2b1b |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:59:47Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-32437ed97ea740149ecb01b64eed2b1b2024-03-03T03:25:26ZengWileyHemaSphere2572-92412023-08-017e71265f810.1097/01.HS9.0000972304.71265.f8202308003-01250P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS.Nawid Albinger0Tobias Bexte1Ahmad Al-Ajami2Philipp Wendel3Leon Buchinger4Alec Gessner5Jamal Alzubi6Vinzenz Särchen7Meike Vogler8Raj Bhayadia9Jan-Henning Klusmann10Nina Möker11Toni Cathomen12Michael A. Rieger13Katharina Imkeller14Evelyn Ullrich151 University Hospital Frankfurt, Children’s Hospital, Experimental Immunology, Frankfurt am Main, Germany1 University Hospital Frankfurt, Children’s Hospital, Experimental Immunology, Frankfurt am Main, Germany2 University Hospital Frankfurt, Neurological Institute/ Edinger Institute, Frankfurt am Main, Germany1 University Hospital Frankfurt, Children’s Hospital, Experimental Immunology, Frankfurt am Main, Germany1 University Hospital Frankfurt, Children’s Hospital, Experimental Immunology, Frankfurt am Main, Germany3 University Hospital Frankfurt, Department of Medicine, Hematology/Oncology, Frankfurt am Main, Germany4 Medical Center – University of Freiburg, Center for Chronic Immunodeficiency, Freiburg im Breisgau, Germany5 Institute for Experimental Cancer Research in Pediatrics, Frankfurt am Main, Germany5 Institute for Experimental Cancer Research in Pediatrics, Frankfurt am Main, Germany6 University Hospital Frankfurt, Children’s Hospital, Frankfurt am Main, Germany6 University Hospital Frankfurt, Children’s Hospital, Frankfurt am Main, Germany7 Miltenyi Biotec, Bergisch Gladbach, Germany4 Medical Center – University of Freiburg, Center for Chronic Immunodeficiency, Freiburg im Breisgau, Germany3 University Hospital Frankfurt, Department of Medicine, Hematology/Oncology, Frankfurt am Main, Germany2 University Hospital Frankfurt, Neurological Institute/ Edinger Institute, Frankfurt am Main, Germany1 University Hospital Frankfurt, Children’s Hospital, Experimental Immunology, Frankfurt am Main, Germanyhttp://journals.lww.com/10.1097/01.HS9.0000972304.71265.f8 |
| spellingShingle | Nawid Albinger Tobias Bexte Ahmad Al-Ajami Philipp Wendel Leon Buchinger Alec Gessner Jamal Alzubi Vinzenz Särchen Meike Vogler Raj Bhayadia Jan-Henning Klusmann Nina Möker Toni Cathomen Michael A. Rieger Katharina Imkeller Evelyn Ullrich P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS. HemaSphere |
| title | P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS. |
| title_full | P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS. |
| title_fullStr | P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS. |
| title_full_unstemmed | P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS. |
| title_short | P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS. |
| title_sort | p1354 crispr cas9 gene editing of immune checkpoint receptor nkg2a improves the anti leukemic efficacy of primary cd33 targeting car nk cells |
| url | http://journals.lww.com/10.1097/01.HS9.0000972304.71265.f8 |
| work_keys_str_mv | AT nawidalbinger p1354crisprcas9geneeditingofimmunecheckpointreceptornkg2aimprovestheantileukemicefficacyofprimarycd33targetingcarnkcells AT tobiasbexte p1354crisprcas9geneeditingofimmunecheckpointreceptornkg2aimprovestheantileukemicefficacyofprimarycd33targetingcarnkcells AT ahmadalajami p1354crisprcas9geneeditingofimmunecheckpointreceptornkg2aimprovestheantileukemicefficacyofprimarycd33targetingcarnkcells AT philippwendel p1354crisprcas9geneeditingofimmunecheckpointreceptornkg2aimprovestheantileukemicefficacyofprimarycd33targetingcarnkcells AT leonbuchinger p1354crisprcas9geneeditingofimmunecheckpointreceptornkg2aimprovestheantileukemicefficacyofprimarycd33targetingcarnkcells AT alecgessner p1354crisprcas9geneeditingofimmunecheckpointreceptornkg2aimprovestheantileukemicefficacyofprimarycd33targetingcarnkcells AT jamalalzubi p1354crisprcas9geneeditingofimmunecheckpointreceptornkg2aimprovestheantileukemicefficacyofprimarycd33targetingcarnkcells AT vinzenzsarchen p1354crisprcas9geneeditingofimmunecheckpointreceptornkg2aimprovestheantileukemicefficacyofprimarycd33targetingcarnkcells AT meikevogler p1354crisprcas9geneeditingofimmunecheckpointreceptornkg2aimprovestheantileukemicefficacyofprimarycd33targetingcarnkcells AT rajbhayadia p1354crisprcas9geneeditingofimmunecheckpointreceptornkg2aimprovestheantileukemicefficacyofprimarycd33targetingcarnkcells AT janhenningklusmann p1354crisprcas9geneeditingofimmunecheckpointreceptornkg2aimprovestheantileukemicefficacyofprimarycd33targetingcarnkcells AT ninamoker p1354crisprcas9geneeditingofimmunecheckpointreceptornkg2aimprovestheantileukemicefficacyofprimarycd33targetingcarnkcells AT tonicathomen p1354crisprcas9geneeditingofimmunecheckpointreceptornkg2aimprovestheantileukemicefficacyofprimarycd33targetingcarnkcells AT michaelarieger p1354crisprcas9geneeditingofimmunecheckpointreceptornkg2aimprovestheantileukemicefficacyofprimarycd33targetingcarnkcells AT katharinaimkeller p1354crisprcas9geneeditingofimmunecheckpointreceptornkg2aimprovestheantileukemicefficacyofprimarycd33targetingcarnkcells AT evelynullrich p1354crisprcas9geneeditingofimmunecheckpointreceptornkg2aimprovestheantileukemicefficacyofprimarycd33targetingcarnkcells |